Source:http://linkedlifedata.com/resource/pubmed/id/14527172
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-10-6
|
pubmed:abstractText |
Stimulation of T cells through the T cell receptor is insufficient for optimal T cell activation. A second activation signal is necessary, being usually provided by the costimulatory molecule CD28. Recently, additional costimulatory pathways have been identified, including inducible costimulator (ICOS) and its ligand B7RP-1. We have examined the role of the B7RP-1/ICOS costimulatory pathway on antigen presentation by B cells, using the I-Ak and I-Ek-positive CH27 B cell line and several different T cell lines. We found that CH27 expressed B7RP-1 and PD-L1 whereas the T cell lines expressed ICOS and PD-1. In the presence of HEL, the T cell hybridomas C10 and 3A9 released IL-2, which is indicative of antigen-specific T cell activation by the CH27 cells. Unexpectedly, blocking antibodies for B7RP-1 and ICOS enhanced the IL-2 response in both T cells. As expected, an increase in the production of IL-2 was seen when blocking antibodies for PD-1 were used. Blocking with antibodies for I-Ak, CD28, B7.1, and B7.2 lead to a decrease in IL-2 production. Additionally we tested a Th1 and a Th2 T cell clone. Blockade of B7RP-1/ICOS lead to an increased IFN-gamma response in Th1 cells (A.E7) and an increased IL-4 response in Th2 cells (D10.G4.1). Intracellular staining also showed an increase in cytokine production when the B7RP-1/ICOS pathway was blocked. In conclusion, the B7RP-1/ICOS pathway is negatively regulating T cell activation by B cells and may play a role similar to that of the PD-L1/PD-1 pathway.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD80,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation...,
http://linkedlifedata.com/resource/pubmed/chemical/Icos protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Inducible T-Cell Co-Stimulator...,
http://linkedlifedata.com/resource/pubmed/chemical/Inducible T-Cell Co-Stimulator...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0360-3997
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
191-200
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14527172-Animals,
pubmed-meshheading:14527172-Antigen Presentation,
pubmed-meshheading:14527172-Antigens, CD80,
pubmed-meshheading:14527172-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:14527172-B-Lymphocytes,
pubmed-meshheading:14527172-Cell Line,
pubmed-meshheading:14527172-Cell Line, Tumor,
pubmed-meshheading:14527172-Down-Regulation,
pubmed-meshheading:14527172-Inducible T-Cell Co-Stimulator Ligand,
pubmed-meshheading:14527172-Inducible T-Cell Co-Stimulator Protein,
pubmed-meshheading:14527172-Mice
|
pubmed:year |
2003
|
pubmed:articleTitle |
Interaction of B7RP-1 with ICOS negatively regulates antigen presentation by B cells.
|
pubmed:affiliation |
Division of Nephrology, Kantonsspital, St. Gallen, Switzerland, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|